Valion Bio, Inc. (VBIO) stock
VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.53+0.02 (+4.05%)
Close on Nov 13, 2026Market cap $2.20MP/E –Yield –
Valion Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Valion Bio's price to book ratio was 0.5× on Nov 11, 2026, against 22.1× a year earlier. Over the last 5 years it ranged from 0.5× to 56.1×, with a median of 14.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −17.2 |
| 2025 | Dec 31, 2025 | 17.7× | −1.4 |
| 2024 | Dec 31, 2024 | 19.1× | +7.6 |
| 2023 | Dec 29, 2023 | 11.4× | −15.4 |
| 2022 | Dec 30, 2022 | 26.8× | – |
See a number that looks wrong?